Concepedia

Peter J. Prince

PJ

Statistics

Publications

6

Citations

157

H-Index

6

Active since

2005

Affiliations

Amgen (United States)(Current)

Peter J. Prince is an author at Amgen (United States) specializing in autoimmune disease, inflammation, and allergy.

Top concepts

Publications per year

2005–2014

6

Publications

6

Off-Target Platelet Activation in Macaques Unique to a Therapeutic Monoclonal Antibody

Michael J. Santostefano, Jacqueline Kirchner, Christine Vissinga et al. · Toxicologic Pathology · 2012 · 43 citations

Clinical pharmacology of <scp>AMG</scp> 181, a gut‐specific human anti‐α<sub>4</sub>β<sub>7</sub> monoclonal antibody, for treating inflammatory bowel diseases

Wei‐Jian Pan, Kathleen Köck, William A. Rees et al. · British Journal of Clinical Pharmacology · 2014 · 35 citations · Full text

Production of ex vivo lipopolysaccharide-induced tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 is suppressed by trans-resveratrol in a concentration-dependent manner.

Jean‐Francois Marier, Keguan Chen, Peter J. Prince et al. · PubMed · 2005 · 31 citations · Full text

, , +15

Assessment of DBS Technology for The Detection of Therapeutic Antibodies

Peter J. Prince, Katherine C Matsuda, MW Retter et al. · Bioanalysis · 2010 · 21 citations

Prediction of clinical pharmacokinetics of AMG 181, a human anti‐<i>α</i><sub>4</sub><i>β</i><sub>7</sub> monoclonal antibody for treating inflammatory bowel diseases

Hong Li, Kathleen Köck, John Wisler et al. · Pharmacology Research & Perspectives · 2014 · 17 citations · Full text

1–5 of 6